202 related articles for article (PubMed ID: 23585523)
1. Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.
Dickmann B; Ahlbrecht J; Ay C; Dunkler D; Thaler J; Scheithauer W; Quehenberger P; Zielinski C; Pabinger I
Haematologica; 2013 Aug; 98(8):1309-14. PubMed ID: 23585523
[TBL] [Abstract][Full Text] [Related]
2. Comment on Ferroni et al.: "Impact of chemotherapy on venous thromboembolism.: Comment to: Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study" HAEMATOL/2012/073338 and HAEMATOL/2013/092528.
Dickmann B; Ahlbrecht J; Ay C; Pabinger I
Haematologica; 2014 Feb; 99(2):e28-9. PubMed ID: 24497569
[No Abstract] [Full Text] [Related]
3. Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study.
Ferroni P; Riondino S; Guadagni F; Roselli M
Haematologica; 2013 Dec; 98(12):e153-4. PubMed ID: 24323987
[No Abstract] [Full Text] [Related]
4. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
[TBL] [Abstract][Full Text] [Related]
5. Association of mean platelet volume with risk of venous thromboembolism and mortality in patients with cancer. Results from the Vienna Cancer and Thrombosis Study (CATS).
Riedl J; Kaider A; Reitter EM; Marosi C; Jäger U; Schwarzinger I; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2014 Apr; 111(4):670-8. PubMed ID: 24306221
[TBL] [Abstract][Full Text] [Related]
6. A clinical prediction model for cancer-associated venous thromboembolism: a development and validation study in two independent prospective cohorts.
Pabinger I; van Es N; Heinze G; Posch F; Riedl J; Reitter EM; Di Nisio M; Cesarman-Maus G; Kraaijpoel N; Zielinski CC; Büller HR; Ay C
Lancet Haematol; 2018 Jul; 5(7):e289-e298. PubMed ID: 29885940
[TBL] [Abstract][Full Text] [Related]
7. The impact of initial cancer stage on the incidence of venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) Cohort.
Gade IL; Braekkan SK; Naess IA; Hansen JB; Cannegieter SC; Overvad K; Jensvoll H; Hammerstrøm J; Blix K; Tjønneland A; Kristensen SR; Severinsen MT
J Thromb Haemost; 2017 Aug; 15(8):1567-1575. PubMed ID: 28585779
[TBL] [Abstract][Full Text] [Related]
8. D-dimer and prothrombin fragment 1 + 2 predict venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
Ay C; Vormittag R; Dunkler D; Simanek R; Chiriac AL; Drach J; Quehenberger P; Wagner O; Zielinski C; Pabinger I
J Clin Oncol; 2009 Sep; 27(25):4124-9. PubMed ID: 19636003
[TBL] [Abstract][Full Text] [Related]
9. Hypercoagulabilty, venous thromboembolism, and death in patients with cancer. A Multi-State Model.
Posch F; Riedl J; Reitter EM; Kaider A; Zielinski C; Pabinger I; Ay C
Thromb Haemost; 2016 Apr; 115(4):817-26. PubMed ID: 26738412
[TBL] [Abstract][Full Text] [Related]
10. Soluble Vascular Endothelial Growth Factor (sVEGF) and the Risk of Venous Thromboembolism in Patients with Cancer: Results from the Vienna Cancer and Thrombosis Study (CATS).
Posch F; Thaler J; Zlabinger GJ; Königsbrügge O; Koder S; Zielinski C; Pabinger I; Ay C
Clin Cancer Res; 2016 Jan; 22(1):200-6. PubMed ID: 26302981
[TBL] [Abstract][Full Text] [Related]
11. Platelet count measured prior to cancer development is a risk factor for future symptomatic venous thromboembolism: the Tromsø Study.
Jensvoll H; Blix K; Brækkan SK; Hansen JB
PLoS One; 2014; 9(3):e92011. PubMed ID: 24642868
[TBL] [Abstract][Full Text] [Related]
12. Comparison of risk prediction scores for venous thromboembolism in cancer patients: a prospective cohort study.
van Es N; Di Nisio M; Cesarman G; Kleinjan A; Otten HM; Mahé I; Wilts IT; Twint DC; Porreca E; Arrieta O; Stépanian A; Smit K; De Tursi M; Bleker SM; Bossuyt PM; Nieuwland R; Kamphuisen PW; Büller HR
Haematologica; 2017 Sep; 102(9):1494-1501. PubMed ID: 28550192
[TBL] [Abstract][Full Text] [Related]
13. Cumulative incidence of venous thromboembolism in patients with advanced cancer in prospective observational study.
Kenmotsu H; Notsu A; Mori K; Omori S; Tsushima T; Satake Y; Miki Y; Abe M; Ogiku M; Nakamura T; Takagi M; Ochiai H; Yasui H; Takahashi T
Cancer Med; 2021 Feb; 10(3):895-904. PubMed ID: 33421344
[TBL] [Abstract][Full Text] [Related]
14. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer.
Li R; Hermann G; Baldini E; Chen A; Jackman D; Kozono D; Nguyen P; Nohria A; Powell G; Mak R
Lung Cancer; 2016 Jun; 96():41-7. PubMed ID: 27133748
[TBL] [Abstract][Full Text] [Related]
15. A Population-Based Cohort Study of Venous Thromboembolism Rates Following Surgery and During Adjuvant Chemotherapy in Patients With Colon Cancer.
Patel SV; Zhang L; Wei XS; Merchant SJ; Nanji S; James PD; Booth CM
Dis Colon Rectum; 2020 Mar; 63(3):336-345. PubMed ID: 32045399
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry.
Ohashi Y; Ikeda M; Kunitoh H; Sasako M; Okusaka T; Mukai H; Fujiwara K; Nakamura M; Oba MS; Kimura T; Ibusuki K; Sakon M
Jpn J Clin Oncol; 2020 Oct; 50(11):1246-1253. PubMed ID: 32715307
[TBL] [Abstract][Full Text] [Related]
17. Growth differentiation factor-15 and prediction of cancer-associated thrombosis and mortality: a prospective cohort study.
Nopp S; Moik F; Kraler S; Englisch C; Preusser M; von Eckardstein A; Pabinger I; Lüscher TF; Ay C
J Thromb Haemost; 2023 Sep; 21(9):2461-2472. PubMed ID: 37192696
[TBL] [Abstract][Full Text] [Related]
18. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
[TBL] [Abstract][Full Text] [Related]
19. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
20. Significance of venous thromboembolism in women with cervical cancer.
Matsuo K; Moeini A; Machida H; Fullerton ME; Shabalova A; Brunette LL; Roman LD
Gynecol Oncol; 2016 Sep; 142(3):405-12. PubMed ID: 27350404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
